Market Research Logo

Global Male Hypogonadism Epidemiology and Patient Flow Analysis - 2017

Global Male Hypogonadism Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Male Hypogonadism patients study in a new report ‘Global Male Hypogonadism Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Male Hypogonadism epidemiology, Male Hypogonadism diagnosed patients, and Male Hypogonadism treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Male Hypogonadism derived from epidemiological analysis, percentage of patients diagnosed with Male Hypogonadism, and percentage of patients treated with a therapy.

The study helps executives estimate Male Hypogonadism market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Male Hypogonadism prevalence, Male Hypogonadism diagnosis rate, and Male Hypogonadism treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Male Hypogonadism Patient Flow
  • Male Hypogonadism Prevalence
  • Male Hypogonadism Diagnosed Patients
  • Male Hypogonadism Treated Patients


1. Male Hypogonadism: Disease Definition
2. Global Male Hypogonadism Patient Flow
2A. Global Male Hypogonadism Prevalence
2B. Global Male Hypogonadism Diagnosed Patients
2C. Global Male Hypogonadism Treated Patients
3. Male Hypogonadism Patient Flow in the US
3A. Male Hypogonadism Prevalence in the US
3B. Male Hypogonadism Diagnosed Patients in the US
3C. Male Hypogonadism Treated Patients in the US
4. Male Hypogonadism Patient Flow in Europe
4A. Male Hypogonadism Prevalence in Europe
4B. Male Hypogonadism Diagnosed Patients in Europe
4C. Male Hypogonadism Treated Patients in Europe
5. Male Hypogonadism Patient Flow in Germany
5A. Male Hypogonadism Prevalence in Germany
5B. Male Hypogonadism Diagnosed Patients in Germany
5C. Male Hypogonadism Treated Patients in Germany
6. Male Hypogonadism Patient Flow in France
6A. Male Hypogonadism Prevalence in France
6B. Male Hypogonadism Diagnosed Patients in France
6C. Male Hypogonadism Treated Patients in France
7. Male Hypogonadism Patient Flow in Spain
7A. Male Hypogonadism Prevalence in Spain
7B. Male Hypogonadism Diagnosed Patients in Spain
7C. Male Hypogonadism Treated Patients in Spain
8. Male Hypogonadism Patient Flow in Italy
8A. Male Hypogonadism Prevalence in Italy
8B. Male Hypogonadism Diagnosed Patients in Italy
8C. Male Hypogonadism Treated Patients in Italy
9. Male Hypogonadism Patient Flow in UK
9A. Male Hypogonadism Prevalence in UK
9B. Male Hypogonadism Diagnosed Patients in UK
9C. Male Hypogonadism Treated Patients in UK
10. Male Hypogonadism Patient Flow in Japan
10A. Male Hypogonadism Prevalence in Japan
10B. Male Hypogonadism Diagnosed Patients in Japan
10C. Male Hypogonadism Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Male Hypogonadism Patient Flow, 2016
Table 2: Global Male Hypogonadism Patient Flow Forecast, 2016 - 2025
Table 3: Male Hypogonadism Patient Flow in the US, 2016
Table 4: Male Hypogonadism Patient Flow Forecast in the US, 2016 - 2025
Table 5: Male Hypogonadism Patient Flow in Europe, 2016
Table 6: Male Hypogonadism Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Male Hypogonadism Patient Flow in Germany, 2016
Table 8: Male Hypogonadism Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Male Hypogonadism Patient Flow in France, 2016
Table 10: Male Hypogonadism Patient Flow Forecast in France, 2016 - 2025
Table 11: Male Hypogonadism Patient Flow in Spain, 2016
Table 12: Male Hypogonadism Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Male Hypogonadism Patient Flow in Italy, 2016
Table 14: Male Hypogonadism Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Male Hypogonadism Patient Flow in UK, 2016
Table 16: Male Hypogonadism Patient Flow Forecast in UK, 2016 - 2025
Table 17: Male Hypogonadism Patient Flow in Japan, 2016
Table 18: Male Hypogonadism Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Male Hypogonadism Patient Flow, 2016
Figure 2: Global Male Hypogonadism Patient Flow Forecast, 2016 - 2025
Figure 3: Male Hypogonadism Patient Flow in the US, 2016
Figure 4: Male Hypogonadism Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Male Hypogonadism Patient Flow in Europe, 2016
Figure 6: Male Hypogonadism Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Male Hypogonadism Patient Flow in Germany, 2016
Figure 8: Male Hypogonadism Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Male Hypogonadism Patient Flow in France, 2016
Figure 10: Male Hypogonadism Patient Flow Forecast in France, 2016 - 2025
Figure 11: Male Hypogonadism Patient Flow in Spain, 2016
Figure 12: Male Hypogonadism Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Male Hypogonadism Patient Flow in Italy, 2016
Figure 14: Male Hypogonadism Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Male Hypogonadism Patient Flow in UK, 2016
Figure 16: Male Hypogonadism Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Male Hypogonadism Patient Flow in Japan, 2016
Figure 18: Male Hypogonadism Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report